SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CEPH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: KurtVedder who wrote (359)5/21/1997 11:40:00 PM
From: harkenman   of 998
 
Have you looked into Cytogen (CYTO) a $5.00 stock with three recent FDA approvals with markets bigger than CEPH target markets. It has a better chance of hitting $20 than CEPH @ $12.5 hitting $20. The gain for CYTO is about 400% while CEPH chances of hitting $20 is low and % gain is less than 70%. Downside risk for CEPH is statiscally huge since they would have to go againts advisory committee recommendation for a drug with doubtfull eficacy. Just an idea (free advice) so you can make up for your loss in CEPH.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News